跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-12
首页
药物
AT-12
AT-12
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Mutilin-Derivative Substituted at Position 12
申请人: TAKADOI MASANORI
优先权: 2004
US
10a-Azalide compound crosslinked at 10a- and 12-positions
申请人: SUGIMOTO TOMOHIRO
优先权: 2007
US
2 件公开
Medicine for expressing interleukin 12 aiming at tumors based on mRNA and preparation method thereof
申请人: JIACHEN XIHAI HANGZHOU BIOTECHNOLOGY CO LTD
优先权: 2021
CN
Phase-change cold accumulation agent used for heat preservation of insulin at 12-18 DEG C
申请人: XIANG HENG WUXI NOVEL PACKAGING TECH CO LTD
优先权: 2017
CN
Garlic powder health care capsule for reducing blood lipids and method for preparing same
申请人: UNIV CHONGQING
优先权: 2006
CN
METHOD FOR REDUCING THE AMOUNT OF TOBACCO-SPECIFIC NITROSAMINES IN A FLUID COMPRISING NICOTINE
申请人: PHILIP MORRIS PRODUCTS S A
优先权: 2024
WO
ANTIVIRAL USE OF PLEUROMUTILINS
申请人: ARIVA MED GMBH
优先权: 2020
CN
EP
US
WO
5 件公开
ANTI-IL-12 ANTIBODIES, COMPOSITIONS, METHODS AND USES
申请人: JANSSEN BIOTECH INC
优先权: 2000
EP
US
4 件公开
药物
反馈